CONJUGATES BETWEEN A BIOPOLYMER AND A PHOTOACTIVATED ANTIMICROBIAL AGENT FOR COMBATING FUNGAL DISEASES OF AGRICULTURAL INTEREST AND METHODS FOR PRODUCING SAID CONJUGATES
20230000075 · 2023-01-05
Inventors
- Denis Alberto FUENTEALBA PATINO (Santiago, CL)
- Luciano Francesco DIBONA VILLANUEVA (Santiago, CL)
- Hector Antonio VALDES GOMEZ (Santiago, CL)
Cpc classification
A01N43/90
HUMAN NECESSITIES
International classification
A01N43/90
HUMAN NECESSITIES
Abstract
This invention relates to the field of control of different fungal diseases in the agricultural industry. Specifically, the invention reports conjugates between biopolymers and a photoactivable agent, which when activated by light generates singlet oxygen, a species known for its antimicrobial capacity. The invention also relates to methods of production of these conjugates and their uses.
Claims
1-11. (canceled)
12. A fungicidal composition for inhibiting growth or combatting fungal infections of fungi of the genera Botritys, Penicillium, and Rhizopus, the fungicidal composition comprising a biopolymer selected from the group consisting of chitosan, modified chitosan, poly-lysine, alginate, modified alginate, cellulose, modified cellulose, and a derivative thereof, conjugated to a photoactivable agent selected from the group consisting of porphyrins, phthalocyanins, naphthalocyanins, chlorines, phenothiazines, acridines, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY), and its derivatives, wherein the photoactivable agent generates oxygen radicals when activated by natural light.
13. The fungicidal composition of claim 12, wherein the biopolymer is at a concentration between 0.1 and 5%.
14. The fungicidal composition of claim 12, wherein the biopolymer is at a concentration between 0.1 and 2.5%.
15. The fungicidal composition of claim 12, wherein the photoactivable agent is at a concentration between 0.1% and 15%.
16. The fungicidal composition of claim 15, wherein the photoactivable agent is at a concentration between 0.1% and 1%.
17. The fungicidal composition of claim 16, wherein the biopolymer is at a concentration of 1% and the photoactivable agent is at a concentration of 1%.
18. The fungicidal composition of claim 12, wherein the biopolymer is chitosan and the photoactivable agent is riboflavin or protoporphyrin IX.
19. A method for preparing the fungicidal composition of claim 12 comprising: a) combining the photoactivable agent (FA) with 4-maleimidophenyl isocyanate (PMPI) to obtain an FA-PMPI derivative; b) treating the biopolymer (BP) with thioglycolic acid, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and N-hydroxysuccinimide to obtain a biopolymer product functionalized with reactive thiol groups (BP-SH); c) reacting the FA-PMPI derivative and the BP-SH in an aqueous solution to obtain a conjugate product; and d) optionally, dialyzing and lyophilizing the conjugate product for storage.
20. The method of claim 19, wherein the biopolymer is chitosan and the photoactivable agent is riboflavin or protoporphyrin IX.
21. A method of treating or preventing gray rot, green rot, or soft rot fungal infections of a plurality of fruits or vegetables comprising contacting the fruits or vegetables with the fungicidal composition of claim 12.
22. A method of treating or preventing fungal infections caused by Botritys cinerea, Penicillium digitatum, and/or Rhizopus stoloniser of a plurality of fruits or vegetables comprising contacting the fruits or vegetables with the fungicidal composition of claim.
23. The fungicidal composition of claim 17, wherein the biopolymer is chitosan and the photoactivable agent is riboflavin or protoporphyrin IX.
24. The method of claim 19, wherein, in step a), the FA is combined with the PMPI at 45° C. in nitrogen atmosphere for 24 h to obtain the FA-PMPI derivative.
25. The method of claim 19, wherein, in step c), the FA-PMPI derivative and the BP-SH are reacted in the aqueous solution at pH 6 for 24 hours to obtain the conjugate product.
Description
BRIEF DESCRIPTION OF FIGURES
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
EXAMPLES
[0053] The following are examples of realization for this invention as described above:
Example 1
Preparation of Hydrolyzed Commercial Chitosan
[0054] A process of hydrolyzing the commercial chitosan used for the fungicide was carried out in order to improve its solubility and reactivity to subsequent processes. It has been observed that the degree of deacetylation of this is important for its biological properties, and therefore this parameter was evaluated. As shown in Table 1 and
Example 2
Synthesis and Characterization of Compounds with Antimicrobial Activity
[0055] The synthesis conditions of the 2 precursors of the biofungicide molecule are presented in
[0056] To obtain the pure precursor for chemical characterization and then its binding with chitosane, a separation was performed by preparative chromatography on board, the band in the middle of the plate corresponds to the RF-PMPI derivative, obtaining a
TABLE-US-00001 TABLE 1 Characterization of commercial chitosan and hydrolyzed chitosan t Mv c System (s) nr nsp [n] g/mol g/mL α K CH 132 5.07 4.07 3.69E+04 39585 6.0E−05 0.96 1.424 CH.sub.H 51 1.96 0.96 2.53E+03 2426 3.0E−04 — — Solvent 26 — — — — — — —
successful separation (
[0057] Additionally, a characterization of the absorption and emission spectra of riboflavin, the RF-PMPI derivative and the chemical conjugate was performed. It is important to know the absorption spectrum because in this way it is known what type of light the molecule absorbs to photoactivate. It absorbs in the region of blue light and UV (white and solar light have these light components present). The fluorescence spectrum is used to know in which region of the light spectrum this molecule emits light, useful for later experiments. As shown in
[0058] Subsequently, an additional characterization was performed in which the life-times and fluorescence anisotropy of riboflavin and riboflavin derivatives were determined. The data obtained are shown in Table 2, and these results show that highlighting riboflavin is chemically bound to the polymeric matrix of chitosan.
TABLE-US-00002 TABLE 2 Life-time and fluorescence anisotropy of RF-based systems System T (ns) α.sub.i r.sub.0 φ (ns) r.sub.∞ RF 4.8 0.278 0.276 0 RF-PMPI 1.6 0.033 0.276 0.374 0 3.9 0.146 CH.sub.H-RF 1.58 0.046 0.237 0.485 0.011 3.75 0.132
Example 3
Determination of Singlet Oxygen Generation by Compounds
[0059] In this example, the capacity of singlet oxygen generation mediated by riboflavin and chitosan-riboflavin conjugate was evaluated. As shown in
Example 4
Quantization of Riboflavin in Conjugates
[0060] The results from Table 3 and
[0061] Concentrations calculated in 3 different ways are within the same order of magnitude, which is good indication that the amount of riboflavin that was achieved by chitosan is within the micromolar magnitude. Therefore, the percentage composition of the final conjugate is: [0062] GLCN: 2.11 m ×10.sup.−4 moles, 70% [0063] GlcNAc: 0.10-×10.sup.−4 moles, 14% [0064] Thiol groups: 61.10-×10.sup.−6 moles, 15% [0065] Riboflavin: 4.3-×10.sup.−6 moles, 1%
[0066] The conjugate possesses 1% riboflavin as a photoactive agent.
Example 5
In vitro Fungicidal Activity of the Chitosan-Photoactive Agent Formulations
[0067] It can be seen in
[0068] Riboflavin has green fluorescence, therefore in
[0069] Subsequently, tests were carried out on Penicillium digitatum and Botrytis cinerea to see the photodynamic fungicidal activity of the conjugate, under conditions closer to the industry and optimal for the growth of both pathogens (20° C., light regime 12/12, Potato Agar culture medium). The results obtained for Botrytis cinerea and Penicillium digitatum can be seen in
[0070] These new results indicate that the conjugate possesses antifungal activity against these 2 pathogens and that in both cases this antifungal effect is enhanced by light (irradiation for one hour with white LED light). In the specific case of Botrytis cinerea, the biofungicide eliminates 100% growth at a concentration of 1% (m/v) under ambient light, whereas, under an irradiation of 1 hours, only 0.5% in concentration of the biofungicide is needed to control 100% of the pathogen. In the case of Penicillium digitatum, total control is obtained with a concentration of 1% under 1 hours of irradiation.
Example 6
Control of Gray Mold (Botrytis cinerea) in Table Grapes
[0071] Additionally, the efficacy of the formulation developed in the present invention, which comprises the light-activable biopolymer, under more challenging conditions, was evaluated. Three treatments were used to demonstrate the technical advantages of this polymer: (1) witness with wound and inoculated with sterile water, (2) standard wound treatment and inoculated with the pathogen, and (3) treatment with the composition of the molecule described in this request to 0.7%, with wound and inoculated with the pathogen.
[0072] The berries used were obtained from a commercial orchard, which had a maturity of more than 16% of soluble solids, and these berries were collected from clusters that had never been treated with fungicides.
[0073] Berries were taken randomly from bunches with adhered pedicel, and were superficially disinfected with sodium hypochlorite at 0.5% for 1 min, followed by 95% ethanol for 30 seconds and rinsed twice with sterile distiled water, ensuring that no residue remains on the berries. They were then allowed to dry at room temperature under laminar flow chamber. The berries collected were distributed in a number of 10 berries with pedicel on metal grids in appropriately sized polyethylene boxes (e.g.: 20×15×10 cm), placing absorbent paper towel moistened with 40 ml sterile water under the grids to assemble wet chambers. The water level was adjusted depending on the size of the container.
[0074] A fixed point was punctured in each berry with a hypodermic syringe and then a 10 μl drop of 10.sup.6 conidia/ml B. cinerea suspension was mounted on the wound using a micropipette.
[0075] Subsequently, wet chambers were closed and maintained at 20° C. and relative humidity (RH)≥90% avoiding the displacement of the drop on the surface of the berry for 24 hours.
[0076] Finally, the treatments were applied (except T1), reselling chambers and arranging containers randomly in a storage chamber at 20° C. and relative humidity (RH)≥90% for 7 days. The incidence of the disease (gray mold) will be assessed 7 days after each treatment is applied.
[0077] Results: [0078] Disease control efficiency T3>Disease control efficiency T2
Example 7
Control of Green Mold (Penicillium digitatum) in Citrus Fruits
[0079] An experimental strategy very similar to the previous example was used. Briefly, fruits were obtained from a commercial orchard at its point of harvest, of uniform size and color, without defects in the shell or deformations, and the fruits were not treated with fungicide prior to collection. The fruits were then disinfected with sodium hypochlorite at 0.5% for 5 minutes, followed by 95% ethanol for 30 seconds and rinsed twice with sterile distiled water, ensuring that no residue remains on the fruits. They were allowed to dry at room temperature. 12 fruits were then taken and distributed in wet polyethylene chambers of an appropriate size according to the size of the fruit. The water level under the wet chamber louvers was adjusted according to the size of the container.
[0080] A puncture was made with the tip of a scalpel not more than 3 mm deep by 3 mm wide in the equatorial area of the fruit. After the above action, the wound was inoculated with a 10 μl drop of conidial suspension of P. digitatum of 10.sup.4 conidia/ml using a micropipette.
[0081] Subsequently, wet chambers were closed and maintained at 20° C. and relative humidity (RH)≥90% avoiding the displacement of the drop on the surface of the berry for 24 hours.
[0082] Finally, the treatments were applied (except T1), reselling chambers and arranging containers randomly in a storage chamber at 20° C. and relative humidity (RH)≥90% for 7 days. The incidence of the disease (green mold) will be assessed 7 days after each treatment is applied.
[0083] It is expected that the development of patients after treatment 3 (T3) is significantly lower than the other treatments. In particular, T3 is expected to be more efficient in inhibiting disease development compared to T2.
[0084] Results: Disease control efficiency T3>Disease control efficiency T2.